drugset / Trial / NCT02573883

Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus

NCT02573883

Phase 3 Completed 52 enrolled Medstar Health Research Institute
RandomizedCrossoverSingle-blindTreatment

Summary

This study is being done to compare the effects, good and bad, of fractionated CO2 laser treatment and clobetasol propionate .05% ointment on vulvar lichen sclerosus.

Timeline

Start
2015-10
Primary completion
2019-09
Completion
2019-09

Drugs

EvaluationDrugModalityDoseRoute
Subject clobetasol propionate Small molecule 0.05 % Topical